Nextech Invest

Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RVMD, ORIC, TYRA, TNGX, RLAY, and represent 85.88% of Nextech Invest's stock portfolio.
  • Added to shares of these 1 stock: MRSN.
  • Started 1 new stock position in MRSN.
  • Reduced shares in these 3 stocks: CRGX (-$11M), Mersana Therapeutics, SPRY.
  • Sold out of its positions in CRGX, Mersana Therapeutics.
  • Nextech Invest was a net seller of stock by $-12M.
  • Nextech Invest has $657M in assets under management (AUM), dropping by 24.33%.
  • Central Index Key (CIK): 0001595430

Tip: Access up to 7 years of quarterly data

Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Nextech Invest

Nextech Invest holds 15 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 54.0 $355M 7.6M 46.70
 View chart
Oric Pharmaceuticals (ORIC) 13.1 $86M 7.2M 12.00
 View chart
Tyra Biosciences (TYRA) 8.6 $57M 4.1M 13.99
 View chart
Tango Therapeutics (TNGX) 7.1 $47M 5.5M 8.40
 View chart
Relay Therapeutics (RLAY) 3.1 $20M 3.8M 5.22
 View chart
Kymera Therapeutics (KYMR) 2.9 $19M 341k 56.60
 View chart
Zymeworks Del (ZYME) 2.9 $19M 1.1M 17.08
 View chart
Arvinas Ord (ARVN) 1.8 $12M 1.4M 8.52
 View chart
Alumis (ALMS) 1.8 $12M 2.9M 3.99
 View chart
Context Therapeutics (CNTX) 1.1 $7.2M 7.4M 0.97
 View chart
Cullinan Oncology (CGEM) 1.0 $6.8M 1.1M 5.93
 View chart
Silverback Therapeutics (SPRY) 1.0 $6.6M -10% 661k 10.05
 View chart
Silence Therapeutics Ads (SLN) 0.8 $4.9M 952k 5.19
 View chart
Mersana Therapeutics (MRSN) 0.6 $3.7M NEW 483k 7.76
 View chart
Boundless Bio (BOLD) 0.2 $1.5M 1.2M 1.23
 View chart

Past Filings by Nextech Invest

SEC 13F filings are viewable for Nextech Invest going back to 2025